Novel preclinical orthotopic and bone metastasis TNBC models for assessment of immunotherapy and chemotherapy responses.

被引：0
|
作者：
Zdrojewska, Justyna [1 ]
Gladwyn-Ng, Ivan [2 ]
Maki-Jouppila, Jenni H. [1 ]
Fagerlund, Katja M. [1 ]
Suominen, Mari I. [1 ]
Horn, Ross [2 ]
Rissanen, Jukka [1 ]
机构：
[1] Pharmatest Serv, Turku, Finland
[2] Tacon Biosci, Rensselaer, NY USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1806
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Novel and Conventional Preclinical Models to Investigate Bone Metastasis
    Tiina E. Kähkönen
    Jenni Bernoulli
    Jussi M. Halleen
    Mari I. Suominen
    Current Molecular Biology Reports, 2019, 5 (1) : 48 - 54
  • [2] Orthotopic syngeneic tumor models for preclinical evaluation of cancer immunotherapy strategies
    Zhang, Juan
    Guo, Sheng
    Wang, Zhensheng
    Li, Zhongliang
    Qiao, Meng
    Shi, Qian
    CANCER RESEARCH, 2016, 76
  • [3] Evaluation of a preclinical model of bone metastasis for the study of adoptive immunotherapy
    Rüttinger, D
    Li, R
    Urba, WJ
    Fox, BA
    Hu, HM
    EUROPEAN SURGICAL RESEARCH, 2003, 35 (04) : 346 - 351
  • [4] A novel orthotopic model of breast cancer metastasis to bone
    Maria Lelekakis
    Jane M. Moseley
    T. John Martin
    Daphne Hards
    Elizabeth Williams
    Patricia Ho
    Darren Lowen
    Jeannie Javni
    Fred R. Miller
    John Slavin
    Robin L. Anderson
    Clinical & Experimental Metastasis, 1999, 17 : 163 - 170
  • [5] A novel orthotopic model of breast cancer metastasis to bone
    Lelekakis, M
    Moseley, JM
    Martin, TJ
    Hards, D
    Williams, E
    Ho, P
    Lowen, D
    Javni, J
    Miller, FR
    Slavin, J
    Anderson, RL
    CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (02) : 163 - 170
  • [6] Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy
    Wege, Anja Kathrin
    BIODRUGS, 2018, 32 (03) : 245 - 266
  • [7] Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy
    Anja Kathrin Wege
    BioDrugs, 2018, 32 : 245 - 266
  • [8] Novel xCT-targeted biologics significantly suppress metastasis, improve survival, and sensitize primary tumors to chemotherapy in TNBC xenograft models
    Gong, He
    Li, Jun
    Becker, Cyrus
    Timmerman, Luika
    Sikandar, Shaheen
    Huang, Yong
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy
    Erstad, Derek J.
    Sojoodi, Mozhdeh
    Taylor, Martin S.
    Ghoshal, Sarani
    Razavi, Allen A.
    Graham-O'Regan, Katherine A.
    Bardeesy, Nabeel
    Ferrone, Cristina R.
    Lanuti, Michael
    Caravan, Peter
    Tanabe, Kenneth K.
    Fuchs, Bryan C.
    DISEASE MODELS & MECHANISMS, 2018, 11 (07)
  • [10] Animal models for preclinical assessment of bone morphogenetic proteins in the spine
    Sandhu, HS
    Khan, SN
    SPINE, 2002, 27 (16) : S32 - S38
12345